POSLUMA
LIVE

Serial Number

90098473

Owner

Blue Earth Diagnostics Limited

Attorney

Rebecca Liebowitz

Filing Date

Aug 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

POSLUMA Trademark

Serial Number: 90098473 • Registration: 6482073

POSLUMA is a trademark filed by Blue Earth Diagnostics Limited on August 6, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Blue Earth Diagnostics Limited (8 trademarks)

Magdalen Centre,

Entity Type: 99

Trademark Details

Filing Date

August 6, 2020

Registration Date

September 14, 2021

Published for Opposition

June 29, 2021

Goods & Services

Diagnostic preparations for medical purposes; medical preparations in the nature of contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use in medical imaging; Positron Emission Tomography (PET) tracing chemicals for medical use; PET tracing chemicals and reagents prepared for ingestion or injection into humans and animals for medical use; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging, namely, contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use with imaging medical equipment; contrast agents for use in medical imaging and molecular imaging; amino acids for use in medical imaging

Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in Positron Emission Tomography (PET) imaging for laboratory and research use; reagents for use in Positron Emission Tomography (PET) imaging for laboratory and research use; diagnostic scanning agents for in-vivo use for medical research use; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use

scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging; medical and scientific research in relation to disease diagnosis; scientific and medical research in relation to molecular imaging; development of molecular imaging products, development of non-medical molecular imaging services; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services

Filing History

REGISTERED-PRINCIPAL REGISTER
Sep 14, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 29, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 29, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 9, 2021 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 26, 2021 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 21, 2021 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2021 CRFA
ASSIGNED TO LIE
May 19, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2020 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2020 GNRT
NON-FINAL ACTION WRITTEN
Dec 1, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2020 NWOS
NEW APPLICATION ENTERED
Aug 10, 2020 NWAP